- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Joint-read CAD systems make U.S. debut
The RSNA meeting is giving new joint-read computer-assisted reader (CAR) software programs their first commercial showing in the U.S. Recently approved by the FDA, Lung CAR and Colon CAR are being displayed by Vital Images and Viatronix.
The RSNA meeting is giving new joint-read computer-assisted reader (CAR) software programs their first commercial showing in the U.S. Recently approved by the FDA, Lung CAR and Colon CAR are being displayed by Vital Images and Viatronix.
Commercial agreements signed days ago with the manufacturer of the systems, software developer Medicsight of London, allow Vital Images to integrate Colon CAR software into the company's InnerviewGI CT colon imaging product line and Viatronix to globally distribute both Lung CAR and Colon CAR.
Medicsight's image analysis software products differ from standard second-read computer-aided detection systems by allowing radiologists to review computer-identified areas of suspicion next to unfiltered images during the same reading. Second-read systems that use CAD as a spot check require radiologists to review images twice.
Lung CAR and Colon CAR both make use of a series of filters that refine the identification of lesion boundaries. Colon CAR can be applied to image data generated from CT colongraphies to find and measure colorectal polyps. Lung CAR can be used to evaluate lesions and nodules on CT lung scans.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
